Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women with Preeclampsia

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Mar 18, 2025

Keywords

ClinConnect Summary

This clinical trial is studying two different ways to help pregnant women with a condition called preeclampsia, which can cause high blood pressure and other serious health issues for both the mother and baby. The trial will compare a relaxation program using virtual reality (VR) with a traditional face-to-face relaxation method. The goal is to see which method is better at improving health outcomes for mothers and their babies during pregnancy.

To participate in this study, women must be at least 18 years old, hospitalized with preeclampsia, and at least 26 weeks pregnant with a single baby. They should be willing to join the study voluntarily. Throughout the trial, participants can expect to practice relaxation techniques, either through VR or in person, to help reduce their stress and potentially improve their health. It's important to note that women with certain conditions, like multiple pregnancies or severe complications, will not be eligible to join. This study aims to explore innovative ways to support expectant mothers facing the challenges of preeclampsia.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Hospitalized with a diagnosis of preeclampsia.
• • Gestational age ≥26 weeks.
• • 18 years or older.
• • Singleton and viable pregnancy.
• • Willing to participate in the study voluntarily.
• Exclusion Criteria:
• • Multiple pregnancy.
• • Pregnancy achieved through assisted reproductive technologies.
• • Hearing or vision impairment in the pregnant individual.
• • Fetal distress requiring emergency intervention.
• • HELLP Syndrome or Eclampsia.
• • History of vertigo.
• Withdrawal Criteria:
• • Cases where live birth does not occur.
• • Participants who voluntarily withdraw from the study.
• • Participants whose general health condition deteriorates during the intervention.
• • Participants experiencing side effects from virtual reality headset use (e.g., dizziness, nausea, headache).
• • Participants who do not practice progressive muscle relaxation at least once a week after the intervention.